Mechanisms of action of Lycium barbarum polysaccharide in protecting against vitiligo mice through modulation of the STAT3-Hsp70-CXCL9/CXCL10 pathway

References

• Al-Refu K. 2012. Vitiligo in children: a clinical-epidemiologic study in Jordan. Pediatr Dermatol. 29(1):114–115.
   PubMed Web of Science ®Google Scholar
• Arowojolu OA, Orlow SJ, Elbuluk N, Manga P. 2017. The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone. Exp Dermatol. 26(7):637–644.
   PubMed Web of Science ®Google Scholar
• Boniface K, Jacquemin C, Darrigade AS, Dessarthe B, Martins C, Boukhedouni N, Vernisse C, Grasseau A, Thiolat D, Rambert J, et al. 2018. Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3. J Invest Dermatol. 138(2):355–364.
   PubMed Web of Science ®Google Scholar
• Boniface K, Seneschal J, Picardo M, Taieb A. 2018. Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy. Clin Rev Allergy Immunol. 54(1):52–67.
   PubMed Web of Science ®Google Scholar
• Denman CJ, Mccracken J, Hariharan V, Klarquist J, Oyarbide-Valencia K, Guevara-Pati OJA, Caroline L. 2008. HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo. J Invest Dermatol. 128(8):2041–2048.
   PubMed Web of Science ®Google Scholar
• Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. 2015. Vitiligo. Lancet. 386(9988):74–84.
   PubMed Web of Science ®Google Scholar
• Gregg RK, Nichols L, Chen Y, Lu B, Engelhard VH. 2010. Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice. J Immunol. 184(4):1909–1917.
   PubMed Web of Science ®Google Scholar
• Harris JE, Harris TH, Weninger W, Wherry EJ, Hunter CA, Turka LA. 2012. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-gamma for autoreactive CD8(+) T-cell accumulation in the skin. J Invest Dermatol. 132(7):1869–1876.
   PubMed Web of Science ®Google Scholar
• Henning SW, Fernandez MF, Mahon JP, Duff R, Azarafrooz F, Guevara-Patino JA, Rademaker AW, Salzman AL, Le Poole IC. 2018. HSP70iQ435A-encoding DNA repigments vitiligo lesions in Sinclair swine. J Invest Dermatol. 138(12):2531–2539.
   PubMed Web of Science ®Google Scholar
• Iannella G, Greco A, Didona D, Didona B, Granata G, Manno A, Pasquariello B, Magliulo G. 2016. Vitiligo: pathogenesis, clinical variants and treatment approaches. Autoimmun Rev. 15(4):335–343.
   PubMed Web of Science ®Google Scholar
• Jacquemin C, Rambert J, Guillet S, Thiolat D, Boukhedouni N, Doutre MS, Darrigade AS, Ezzedine K, Blanco P, Taieb A, et al. 2017. Heat shock protein 70 potentiates interferon alpha production by plasmacytoid dendritic cells: relevance for cutaneous lupus and vitiligo pathogenesis. Br J Dermatol. 177(5):1367–1375.
   PubMed Web of Science ®Google Scholar
• Li H, Li Z, Peng L, Jiang N, Liu Q, Zhang E, Liang B, Li R, Zhu H. 2017. Lycium barbarum polysaccharide protects human keratinocytes against UVB-induced photo-damage. Free Radic Res. 51(2):200–210.
   PubMed Web of Science ®Google Scholar
• Li Z, Peng L, Jiang N, Liu Q, Zhang E, Mo Z, Dai X, Li H, Liang B, Li R. 2017. Study on the role of Nrf2/Bach1 pathway in the Lycium barbarum polysaccharide against UV-induced acute damage in HaCaT keratinocytes. Chin J Dermatovenereol. 11:1169–1174. Chinese.
   Google Scholar
• Mosenson JA, Flood K, Klarquist J, Eby JM, Koshoffer A, Boissy RE, Overbeck A, Tung RC, Le Poole IC. 2014. Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress. Pigment Cell Melanoma Res. 27(2):209–220.
   PubMed Web of Science ®Google Scholar
• Mosenson JA, Zloza A, Klarquist J, Barfuss AJ, Guevara-Patino JA, Poole IC. 2012. HSP70i is a critical component of the immune response leading to vitiligo. Pigment Cell Melanoma Res. 25(1):88–98.
   PubMed Web of Science ®Google Scholar
• Mumtaz H, Anis S, Akhtar A, Rubab M, Zafar A, Niazi N, Bahadur H, Talpur AS, Shafiq MA, Fatima T. 2020. Efficacy of tacrolimus versus clobetasol in the treatment of vitiligo. Cureus. 12(12):e11985.
   PubMed Web of Science ®Google Scholar
• Rashighi M, Harris JE. 2017. Vitiligo pathogenesis and emerging treatments. Dermatol Clin. 35(2):257–265.
   PubMed Web of Science ®Google Scholar
• Samaka RM, Basha MA, Menesy D. 2019. Role of Janus kinase 1 and signal transducer and activator of transcription 3 in vitiligo. Clin Cosmet Investig Dermatol. 12:469–480.
   PubMed Web of Science ®Google Scholar
• Sehgal VN, Srivastava G. 2007. Vitiligo: compendium of clinico-epidemiological features. Indian J Dermatol Venereol Leprol. 73(3):149–156.
   PubMed Web of Science ®Google Scholar
• Strassner JP, Rashighi M, Ahmed RM, Richmond JM, Harris JE. 2017. Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity. J Am Acad Dermatol. 76(5):847.e5–855.e5.
   Web of Science ®Google Scholar
• Taieb A, Alomar A, Bohm M, Dell’Anna ML, De Pase A, Eleftheriadou V, Ezzedine K, Gauthier Y, Gawkrodger DJ, Jouary T, et al. 2013. Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol. 168(1):5–19.
   PubMed Web of Science ®Google Scholar
• Van den Boorn JG, Melief CJ, Luiten RM. 2011. Monobenzone-induced depigmentation: from enzymatic blockade to autoimmunity. Pigment Cell Melanoma Res. 24(4):673–679.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li S, Li C. 2019. Perspectives of new advances in the pathogenesis of vitiligo: from oxidative stress to autoimmunity. Med Sci Monit. 25:1017–1023.
   PubMed Web of Science ®Google Scholar
• Xie H, Zhou F, Liu L, Zhu G, Li Q, Li C, Gao T. 2016. Vitiligo: how do oxidative stress-induced autoantigens trigger autoimmunity? J Dermatol Sci. 81(1):3–9.
   PubMed Web of Science ®Google Scholar
• Yang L, Yang S, Lei J, Hu W, Chen R, Lin F, Xu AE. 2018. Role of chemokines and the corresponding receptors in vitiligo: a pilot study. J Dermatol. 45(1):31–38.
   PubMed Web of Science ®Google Scholar
• Zhang L, Gu J, Chen Y, Zhang L. 2013. A study on four antioxidation effects of Lycium barbarum polysaccharides in vitro. Afr J Tradit Complement Altern Med. 10(6):494–498.
   PubMedGoogle Scholar
• Zhao R, Hao W, Ma B, Chen Z. 2015. Improvement effect of Lycium barbarum polysaccharide on sub-health mice. Iran J Basic Med Sci. 18(12):1245–1252.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Wang S, Xu A. 2013. A mouse model of vitiligo induced by monobenzone. Exp Dermatol. 22(7):499–501.
   PubMed Web of Science ®Google Scholar